Buy or sell Verge Genomics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Verge Genomics Stock

Drug Discovery

Founded

2015

Notable Investors

Draper Associates

Headquarters

San Francisco CA, US

Total Funding

$36.7M

About Verge Genomics Stock

Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.

Investors

Funding History

June 2018$150K
June 2018$370K
June 2018$100K
June 2018$3.4M
June 2018$4.5M
June 2018$28.2M

Management

Co-Founder & Chief Executive Officer

Alice Zhang

Chief Business Officer

Jane Rhodes

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Verge Genomics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo